High doses of GLP-1 receptor agonist resulting in complete cessation of gastric emptying are not usually associated with gastrointestinal symptoms, which appear to be centrally mediated
Summary: Health vs Hype Many people exploring GLP-1 patches may be doing so out of frustration, stalled progress, or confusion about safe weight loss options
Retatrutide has shown greater average weight loss than Mounjaro in separate clinical trials, but it is not currently approved or available
Peptide Therapy Explained in Plain English A simpler explanation of what peptide therapy is, why patients ask about it and why provider review matters
Resources We Trust Cleveland Clinic: Answering Your Questions About GLP-1s Mayo Clinic: Health Benefits of Semaglutide Beyond Weight Loss Harvard Health Publishing: GLP-1 Diabetes and Weight-Loss Drug Side Effects University of Missouri: Thinking About Microdosing GLP-1
The author and Parahealth assume no liability for side effects, injury, or adverse events resulting from the use of the information discussed in this article.
